Palma, Paolo <br/><br/>
Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.  [electronic resource] 

 -  Biologicals : journal of the International Association of Biological Standardization  Mar 2012 
 - 134-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-8320 
<br/><br/><label>Standard No.: </label>10.1016/j.biologicals.2011.12.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Antibodies, Viral--blood<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Immunologic<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Immunization Schedule<br/>Influenza A Virus, H1N1 Subtype--immunology<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--complications<br/>Male<br/>Polysorbates--administration & dosage<br/>Prospective Studies<br/>Safety<br/>Squalene--administration & dosage<br/>Young Adult